Suvretta Capital Management »

Avidity Biosciences Ord shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $33M 750k 43.57

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcutis Biotherapeutics (ARQT)
Benitec Biopharma Com New (BNTC)
Meta Platforms Cl A (META)
Legend Biotech Corp Sponsored Ads (LEGN)
89bio (ETNB)
Immatics SHS (IMTX)
Coca-Cola Company (KO)
Ge Aerospace Com New (GE)
NVIDIA Corporation (NVDA)
Eyepoint Pharmaceuticals Com New (EYPT)
Biohaven (BHVN)
Mineralys Therapeutics (MLYS)
Home Depot (HD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Suvretta Capital Management

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
Vanguard Group
Rtw Investments
Wellington Management Company
BlackRock
RA Capital Management
venBio Select Advisor
State Street Corporation
Geode Capital Management
Polar Capital Holdings
Bellevue Group
Casdin Capital
Goldman Sachs Group
OrbiMed Advisors

View all funds holding Avidity Biosciences Ord